These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8049 related articles for article (PubMed ID: 14708716)

  • 1. HLA-G in melanoma: can the current controversies be solved?
    Chang CC; Ferrone S
    Semin Cancer Biol; 2003 Oct; 13(5):361-9. PubMed ID: 14708716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms.
    Chang CC; Murphy SP; Ferrone S
    Hum Immunol; 2003 Nov; 64(11):1057-63. PubMed ID: 14602236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis.
    Rouas-Freiss N; Bruel S; Menier C; Marcou C; Moreau P; Carosella ED
    Int J Cancer; 2005 Oct; 117(1):114-22. PubMed ID: 15880415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
    Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
    Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-G expression in human melanoma cells: protection from NK cytolysis.
    Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
    J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.
    Paul P; Rouas-Freiss N; Khalil-Daher I; Moreau P; Riteau B; Le Gal FA; Avril MF; Dausset J; Guillet JG; Carosella ED
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4510-5. PubMed ID: 9539768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.
    Paul P; Cabestré FA; Le Gal FA; Khalil-Daher I; Le Danff C; Schmid M; Mercier S; Avril MF; Dausset J; Guillet JG; Carosella ED
    Cancer Res; 1999 Apr; 59(8):1954-60. PubMed ID: 10213506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
    Yan WH; Lin AF; Chang CC; Ferrone S
    Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-G in melanoma: A new strategy to escape from immunosurveillance?
    Ugurel S; Reinhold U; Tilgen W
    Onkologie; 2002 Apr; 25(2):129-34. PubMed ID: 12006763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells.
    Fukushima Y; Oshika Y; Nakamura M; Tokunaga T; Hatanaka H; Abe Y; Yamazaki H; Kijima H; Ueyama Y; Tamaoki N
    Int J Mol Med; 1998 Sep; 2(3):349-51. PubMed ID: 9855710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies.
    Bukur J; Seliger B
    Semin Cancer Biol; 2003 Oct; 13(5):353-9. PubMed ID: 14708715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G expression in malignant melanoma.
    Rebmann V; Wagner S; Grosse-Wilde H
    Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines.
    Poláková K; Bandzuchová E; Kuba D; Russ G
    Leuk Res; 2009 Apr; 33(4):518-24. PubMed ID: 18823661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract.
    Hansel DE; Rahman A; Wilentz RE; Shih IeM; McMaster MT; Yeo CJ; Maitra A
    Int J Gastrointest Cancer; 2005; 35(1):15-23. PubMed ID: 15722570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
    Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
    Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression.
    Willers J; Urosevic M; Laine E; Geertsen R; Kündig T; Burg G; Dummer R
    J Invest Dermatol; 2001 Dec; 117(6):1498-504. PubMed ID: 11886514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-G in the human placenta: expression and potential functions.
    Le Bouteiller P
    Biochem Soc Trans; 2000 Feb; 28(2):208-12. PubMed ID: 10816129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia modulates HLA-G gene expression in tumor cells.
    Mouillot G; Marcou C; Zidi I; Guillard C; Sangrouber D; Carosella ED; Moreau P
    Hum Immunol; 2007 Apr; 68(4):277-85. PubMed ID: 17400064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA-E molecule induction on the surface of tumor cells protects them from cytotoxic lymphocytes].
    Berezhnoĭ AE; Chernisheva AD; Zakeeva IR; Danilova AB; Danilov AO; Moiseenko VM; Geraghty D; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
    Vopr Onkol; 2009; 55(2):224-9. PubMed ID: 19514381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HLA-G: a tolerance molecule implicated in the escape of tumors from immunosurveillance].
    Paul P; Rouas-Freiss N; Carosella ED
    Pathol Biol (Paris); 1999 Oct; 47(8):766-70. PubMed ID: 10573693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 403.